Khanu
Venture capitalPre-Seed–Seed
Investment thesis
KHAN focuses on closing the translation gap between academic science and marketable pharmaceutical products, particularly in drug discovery. It partners with the Lead Discovery Center to provide industry-standard drug discovery services and has a strategic co-funding partnership with the Max Planck Society to jointly invest, on a 50:50 basis, in promising early-stage academic drug discovery projects originating from Max Planck Institutes. The firm is backed by institutional partners including the European Investment Fund (via InnovFin Equity and EU/EFSI backing), the Max Planck Foundation, Austria Wirtschaftsservice, and family office Thyssen'sche Handelsgesellschaft.
Source: firm website, verified Aug 7, 2026.
What they invest in
from 3 of 6 portfolio companiesImpact & Social Good ×2Deep Tech ×1Fintech ×1GovTech ×1SaaS ×1
HQs:Austria×1Germany×1
Investments · 6 tracked
founders shown can be your intro pathThe aws Fördermanager is an online platform for creating, collaboratively editing, and managing funding/grant applications, letting users track application status, key deadlines, store confidential documents, and handle investment accounting.
GovTechSaaS
The European Investment Fund (EIF) provides debt and equity financing to European SMEs and infrastructure projects across their development stages, channelling funding through funds and intermediaries.
FintechImpact & Social Good
Announced a €4.45 million seed financing to advance its covalent allosteric inhibitor platform addressing unmet medical needs in oncology.
The Max Planck Foundation is a German charitable foundation, established in 2006 by private donors, that channels private funding to basic research at the institutes of the Max Planck Society.
Deep TechImpact & Social Good
Frequently asked questions
- What stage does Khanu invest at?
- Khanu invests at the Pre-Seed, Seed stages.
- What sectors does Khanu focus on?
- Khanu focuses on Biotech, Deep Tech, Healthtech, Medical Devices.
Similar investors
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
SV Tech Ventures is a Palo Alto-based venture capital firm investing in early-stage, high-tech startups, offering hands-on support with strategy, product, fundraising, and hiring across its funds.
Okapi Venture Capital is a seed and early-stage venture firm founded in 2005, investing in information technology and life science companies.
UTEC is a venture capital firm that invests in seed and early-stage technology companies and is affiliated with the University of Tokyo.
Pillar VC is an early-stage venture capital firm that partners with technical founders at inception to build companies from breakthrough technology.